Sumatriptan: efficacy and contribution to migraine mechanisms.
Pearce
J M
JM
D000284:Administration, Oral; D000818:Animals; D001921:Brain / Q000098:blood supply / Q000503:physiopathology; D006801:Humans; D007211:Indoles / Q000627:therapeutic use*; D007279:Injections, Subcutaneous; D008881:Migraine Disorders / Q000188:drug therapy* / Q000503:physiopathology; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000502:physiology; D011985:Receptors, Serotonin / Q000187:drug effects / Q000502:physiology; D012701:Serotonin / Q000502:physiology; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use*; D013449:Sulfonamides / Q000627:therapeutic use*; D018170:Sumatriptan; D014662:Vasoconstrictor Agents / Q000627:therapeutic use*
D007211:Indoles; D011985:Receptors, Serotonin; D017366:Serotonin Receptor Agonists; D013449:Sulfonamides; D014662:Vasoconstrictor Agents; D012701:Serotonin; D018170:Sumatriptan